Article
Pharmacokinetic Modeling and Monte Carlo Simulation to Predict Interindividual Variability in Human Exposure to Oseltamivir and Its Active Metabolite, Ro 64-0802.
The AAPS journal - 1 Jan 2017
Ito Mototsugu, Kusuhara Hiroyuki, Ose Atsushi, Kondo Tsunenori, Tanabe Kazunari, Nakayama Hideki, Horita Shigeru, Fujita Takuya, Sugiyama Yuichi
Abstract excerpt
Oseltamivir (Tamiflu®) is a prodrug of Ro 64-0802, a selective inhibitor of influenza virus neuraminidase. There is a possible relationship between oseltamivir treatment and neuropsychiatric adverse events; although this has not been established, close monitoring is recommended on the prescription label. The objective of this study was to predict interindividual variability of human exposure to oseltamivir and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
